Overview
Jing-kang He practices practicing medicine in Suzhou, China.
Their clinical expertise encompasses Inflammatory Myofibroblastic Tumor and Lung Adenocarcinoma.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jing-kang He
Is Jing-kang He a top-rated expert for Inflammatory Myofibroblastic Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Jing-kang He is classified as an Experienced expert for Inflammatory Myofibroblastic Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jing-kang He participate in research or clinical trials?
Yes. Jing-kang He has published 8 articles and abstracts on conditions like Inflammatory Myofibroblastic Tumor. You can view a list of Jing-kang He's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Inflammatory Myofibroblastic Tumor
- Lung AdenocarcinomaHe isExperienced. Learn about Lung Adenocarcinoma.